Genetic polymorphisms linked to susceptibility to malaria

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Driss, Adel ^a   Hibbert, Jacqueline M ^a   Wilson, Nana O ^a   Iqbal, Shareen A ^b   Adamkiewicz, Thomas V ^a   Stiles, Jonathan K ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CYTOKINE RECEPTOR; FERRITIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOPHORIN A; HAPTOGLOBIN; HEAT SHOCK PROTEIN; HEME OXYGENASE 1; HEMOGLOBIN C; HEMOGLOBIN E; HEMOGLOBIN S; INDUCIBLE NITRIC OXIDE SYNTHASE; TOLL LIKE RECEPTOR;

ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; BLOOD GROUP ABO SYSTEM; CELL ADHESION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DISEASE SEVERITY; ELLIPTOCYTOSIS; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; HOST PARASITE INTERACTION; IMMUNE RESPONSE; MALARIA; MIXED INFECTION; OXIDATIVE STRESS; PHENOTYPIC VARIATION; PLASMODIUM FALCIPARUM; PROPHYLAXIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; PATHOGENICITY; REVIEW;

GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC;

EID: 80052830499     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-271     Document Type: Article

References (137)

1. The global distribution of clinical episodes of Plasmodium falciparum malaria. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, Nature 2005 434 214 217 10.1038/nature03342 15759000 (Pubitemid 40388051)
2. Heritability of malaria in Africa. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN, PLoS Med 2005 2 340 10.1371/journal.pmed.0020340 16259530 (Pubitemid 43020984)
3. Genetic variability in response to infection: malaria and after. Weatherall DJ, Clegg JB, Genes Immun 2002 3 331 337 10.1038/sj.gene.6363878 12209359 (Pubitemid 38967560)
4. The immunogenetics of resistance to malaria. Hill AV, Proc Assoc Am Physicians 1999 111 272 277 10.1046/j.1525-1381.1999.99234.x 10417733 (Pubitemid 29331457)
5. Why do some African children develop severe malaria? Greenwood B, Marsh K, Snow R, Parasitol Today 1991 7 277 281 10.1016/0169-4758(91)90096-7 15463389 (Pubitemid 121007888)
6. Genetics of susceptibility to Plasmodium falciparum: from classical malaria resistance genes towards genome-wide association studies. Verra F, Mangano VD, Modiano D, Parasite Immunol 2009 31 234 253 10.1111/j.1365-3024. 2009.01106.x 19388945
7. Protection afforded by sickle-cell trait against subtertian malareal infection. Allison AC, BMJ 1954 1 290 294 10.1136/bmj.1.4857.290 13115700
8. Protective effects of the sickle cell gene against malaria morbidity and mortality. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, Nahlen BL, Lal AA, Udhayakumar V, Lancet 2002 359 1311 1312 10.1016/S0140-6736(02)08273-9 11965279 (Pubitemid 34310639)
9. Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia. Allen SJ, Bennett S, Riley EM, Rowe PA, Jakobsen PH, O'Donnell A, Greenwood BM, Trans R Soc Trop Med Hyg 1992 86 494 498 10.1016/0035-9203(92)90083-O 1475814
10. Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait. Le Hesran JY, Personne I, Personne P, Fievet N, Dubois B, Beyeme M, Boudin C, Cot M, Deloron P, Int J Epidemiol 1999 28 793 798 10.1093/ije/28.4.793 10480713 (Pubitemid 29401344)
11. Simulation of the diffusion of the beta-globin variants in the Old World. Livingstone FB, Hum Biol 1989 61 297 309 2680886 (Pubitemid 19257148)
12. Study on association between genetic polymorphisms of haem oxygenase-1, tumour necrosis factor, cadmium exposure and malaria pathogenicity and severity. Kuesap J, Hirayama K, Kikuchi M, Ruangweerayut R, Na-Bangchang K, Malar J 9 260
13. HO-1 polymorphism as a genetic determinant behind the malaria resistance afforded by haemolytic disorders. Garcia-Santos D, Chies JA, Med Hypotheses 2010 74 807 813 10.1016/j.mehy.2009.12.010 20106603
14. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora A, Rodrigues CD, Gregoire IP, Cunha-Rodrigues M, Portugal S, Soares MP, Mota MM, Nat Med 2007 13 703 710 10.1038/nm1586 17496899 (Pubitemid 46889755)
15. Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children. Sambo MR, Trovoada MJ, Benchimol C, Quinhentos V, Goncalves L, Velosa R, Marques MI, Sepulveda N, Clark TG, Mustafa S, Wagner O, Coutinho A, Penha-Goncalves C, PLoS One 5 11141
16. Epistatic interactions between genetic disorders of hemoglobin can explain why the sickle-cell gene is uncommon in the Mediterranean. Penman BS, Pybus OG, Weatherall DJ, Gupta S, Proc Natl Acad Sci USA 2009 106 21242 21246 10.1073/pnas.0910840106 19955437
17. Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Williams TN, Mwangi TW, Wambua S, Peto TE, Weatherall DJ, Gupta S, Recker M, Penman BS, Uyoga S, Macharia A, Mwacharo JK, Snow RW, Marsh K, Nat Genet 2005 37 1253 1257 10.1038/ng1660 16227994 (Pubitemid 41568709)
18. Genomewide analysis of the host response to malaria in Kenyan children. Griffiths MJ, Shafi MJ, Popper SJ, Hemingway CA, Kortok MM, Wathen A, Rockett KA, Mott R, Levin M, Newton CR, Marsh K, Relman DA, Kwiatkowski DP, J Infect Dis 2005 191 1599 1611 10.1086/429297 15838786 (Pubitemid 40656747)
19. Genome-wide linkage analysis of malaria infection intensity and mild disease. Timmann C, Evans JA, Konig IR, Kleensang A, Ruschendorf F, Lenzen J, Sievertsen J, Becker C, Enuameh Y, Kwakye KO, Opoku E, Browne EN, Ziegler A, Nurnberg P, Horstmann RD, PLoS Genet 2007 3 48 10.1371/journal.pgen.0030048 17381244 (Pubitemid 46535757)
20. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Rihet P, Traore Y, Abel L, Aucan C, Traore-Leroux T, Fumoux F, Am J Hum Genet 1998 63 498 505 10.1086/301967 9683598 (Pubitemid 30418631)
21. Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal. Sakuntabhai A, Ndiaye R, Casademont I, Peerapittayamongkol C, Rogier C, Tortevoye P, Tall A, Paul R, Turbpaiboon C, Phimpraphi W, Trape JF, Spiegel A, Heath S, Mercereau-Puijalon O, Dieye A, Julier C, PLoS One 2008 3 2000 10.1371/journal.pone.0002000 18431485 (Pubitemid 352011831)
22. Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Ockenhouse CF, Hu WC, Kester KE, Cummings JF, Stewart A, Heppner DG, Jedlicka AE, Scott AL, Wolfe ND, Vahey M, Burke DS, Infect Immun 2006 74 5561 5573 10.1128/IAI.00408-06 16988231 (Pubitemid 44484539)
23. Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. Torcia MG, Santarlasci V, Cosmi L, Clemente A, Maggi L, Mangano VD, Verra F, Bancone G, Nebie I, Sirima BS, Liotta F, Frosali F, Angeli R, Severini C, Sannella AR, Bonini P, Lucibello M, Maggi E, Garaci E, Coluzzi M, Cozzolino F, Annunziato F, Romagnani S, Modiano D, Proc Natl Acad Sci USA 2008 105 646 651 10.1073/pnas.0709969105 18174328 (Pubitemid 351171762)
24. Genome-wide and fine-resolution association analysis of malaria in West Africa. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG, Kivinen K, Bojang KA, Conway DJ, Pinder M, Sirugo G, Sisay-Joof F, Usen S, Auburn S, Bumpstead SJ, Campino S, Coffey A, Dunham A, Fry AE, Green A, Gwilliam R, Hunt SE, Inouye M, Jeffreys AE, Mendy A, Palotie A, Potter S, Ragoussis J, Rogers J, Rowlands K, Somaskantharajah E, Whittaker P, Widden C, Donnelly P, Howie B, Marchini J, Morris A, Sanjoaquin M, Achidi EA, Agbenyega T, Allen A, Amodu O, Corran P, Djimde A, Dolo A, Doumbo OK, Drakeley C, Dunstan S, Evans J, Farrar J, Fernando D, Hien TT, Horstmann RD, Ibrahim M, Karunaweera N, Kokwaro G, Koram KA, Lemnge M, Makani J, Marsh K, Michon P, Modiano D, Molyneux ME, Mueller I, Parker M, Peshu N, Plowe CV, Puijalon O, Reeder J, Reyburn H, Riley EM, Sakuntabhai A, Singhasivanon P, Sirima S, Tall A, Taylor TE, Thera M, Troye-Blomberg M, Williams TN, Wilson M, Kwiatkowski DP, Wellcome Trust Case Control C, Malaria Genomic Epidemiology N, Nat Genet 2009 41 657 665 10.1038/ng.388 19465909
25. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA, PLoS Med 2007 4 66 10.1371/journal.pmed.0040066 17355169 (Pubitemid 46495319)
26. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Fry AE, Griffiths MJ, Auburn S, Diakite M, Forton JT, Green A, Richardson A, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Rockett KA, Kwiatkowski DP, Hum Mol Genet 2008 17 567 576 18003641 (Pubitemid 351201769)
27. The effects of human population structure on large genetic association studies. Marchini J, Cardon LR, Phillips MS, Donnelly P, Nat Genet 2004 36 512 517 10.1038/ng1337 15052271 (Pubitemid 38620038)
28. Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Sinha S, Mishra SK, Sharma S, Patibandla PK, Mallick PK, Sharma SK, Mohanty S, Pati SS, Mishra SK, Ramteke BK, Bhatt R, Joshi H, Dash AP, Ahuja RC, Awasthi S, Venkatesh V, Habib S, Malar J 2008 7 13 10.1186/1475-2875-7-13 18194515 (Pubitemid 351270258)
29. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Agarwal A, Guindo A, Cissoko Y, Taylor JG, Coulibaly D, Kone A, Kayentao K, Djimde A, Plowe CV, Doumbo O, Wellems TE, Diallo D, Blood 2000 96 2358 2363 11001883
30. How malaria has affected the human genome and what human genetics can teach us about malaria. Kwiatkowski DP, Am J Hum Genet 2005 77 171 192 10.1086/432519 16001361 (Pubitemid 41022702)
31. Soluble factors from Plasmodium falciparum-infected erythrocytes induce apoptosis in human brain vascular endothelial and neuroglia cells. Wilson NO, Huang MB, Anderson W, Bond V, Powell M, Thompson WE, Armah HB, Adjei AA, Gyasi R, Tettey Y, Stiles JK, Mol Biochem Parasitol 2008 162 172 176 10.1016/j.molbiopara.2008.09.003 18848585
32. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, Luster AD, Proc Natl Acad Sci USA 2008 105 4814 4819 10.1073/pnas.0801544105 18347328 (Pubitemid 351753829)
33. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Lucas R, Juillard P, Decoster E, Redard M, Burger D, Donati Y, Giroud C, Monso-Hinard C, De Kesel T, Buurman WA, Moore MW, Dayer JM, Fiers W, Bluethmann H, Grau GE, Eur J Immunol 1997 27 1719 1725 10.1002/eji.1830270719 9247583 (Pubitemid 27302855)
34. A role for Fas-Fas ligand interactions during the late-stage neuropathological processes of experimental cerebral malaria. Potter SM, Chan-Ling T, Rosinova E, Ball HJ, Mitchell AJ, Hunt NH, J Neuroimmunol 2006 173 96 107 10.1016/j.jneuroim.2005.12.004 16414123
35. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, Crawford S, Joel PK, Singh MP, Nagpal AC, Dash AP, Udhayakumar V, Singh N, Stiles JK, Malar J 2008 7 83 10.1186/1475-2875-7-83 18489763 (Pubitemid 351754711)
36. Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women. Wilson NO, Bythwood T, Solomon W, Jolly P, Yatich N, Jiang Y, Shuaib F, Adjei AA, Anderson W, Stiles JK, Infect Dis Obstet Gynecol 2010
37. CXCL4 and CXCL10 predict risk of fatal cerebral malaria. Wilson NO, Jain V, Roberts CE, Lucchi N, Joel PK, Singh MP, Nagpal AC, Dash AP, Udhayakumar V, Singh N, Stiles JK, Dis Markers 30 39 49
38. Macrophage migration inhibitory factor is associated with mortality in cerebral malaria patients in India. Jain V, McClintock S, Nagpal AC, Dash AP, Stiles JK, Udhayakumar V, Singh N, Lucchi NW, BMC Res Notes 2009 2 36 10.1186/1756-0500-2-36 19284533
39. Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Lolis E, Curr Opin Pharmacol 2001 1 662 668 10.1016/S1471-4892(01)00112-6 11757824 (Pubitemid 33586010)
40. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. McDevitt MA, Xie J, Shanmugasundaram G, Griffith J, Liu A, McDonald C, Thuma P, Gordeuk VR, Metz CN, Mitchell R, Keefer J, David J, Leng L, Bucala R, J Exp Med 2006 203 1185 1196 10.1084/jem.20052398 16636133 (Pubitemid 43736589)
41. Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. Awandare GA, Hittner JB, Kremsner PG, Ochiel DO, Keller CC, Weinberg JB, Clark IA, Perkins DJ, Clin Immunol 2006 119 219 225 10.1016/j.clim.2005.12.003 16461006
42. A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria. De Mast Q, Sweep FC, McCall M, Geurts-Moespot A, Hermsen C, Calandra T, Netea MG, Sauerwein RW, van der Ven AJ, Parasite Immunol 2008 30 133 138 10.1111/j.1365-3024.2007.01008.x 18179626 (Pubitemid 351171235)
43. Acute lung injury and acute respiratory distress syndrome in malaria. Mohan A, Sharma SK, Bollineni S, J Vector Borne Dis 2008 45 179 193 18807374
44. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Price RN, Douglas NM, Anstey NM, Curr Opin Infect Dis 2009 22 430 435 10.1097/QCO.0b013e32832f14c1 19571748
45. Hidden burden of malaria in Indian women. Sharma VP, Malar J 2009 8 281 10.1186/1475-2875-8-281 19995437
46. Sickle cell disease in the post genomic era: a monogenic disease with a polygenic phenotype. Driss A, Asare KO, Hibbert JM, Gee BE, Adamkiewicz TV, Stiles JK, Genomics Insights 2009 2009 23 48 20401335
47. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Modiano D, Luoni G, Sirima BS, Simpore J, Verra F, Konate A, Rastrelli E, Olivieri A, Calissano C, Paganotti GM, D'Urbano L, Sanou I, Sawadogo A, Modiano G, Coluzzi M, Nature 2001 414 305 308 10.1038/35104556 11713529 (Pubitemid 33097806)
48. Influence of hemoglobin E trait on the severity of Falciparum malaria. Hutagalung R, Wilairatana P, Looareesuwan S, Brittenham GM, Aikawa M, Gordeuk VR, J Infect Dis 1999 179 283 286 10.1086/314561 9841856 (Pubitemid 29028372)
49. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Chotivanich K, Udomsangpetch R, Pattanapanyasat K, Chierakul W, Simpson J, Looareesuwan S, White N, Blood 2002 100 1172 1176 12149194 (Pubitemid 34864268)
50. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Cholera R, Brittain NJ, Gillrie MR, Lopera-Mesa TM, Diakite SA, Arie T, Krause MA, Guindo A, Tubman A, Fujioka H, Diallo DA, Doumbo OK, Ho M, Wellems TE, Fairhurst RM, Proc Natl Acad Sci USA 2008 105 991 996 10.1073/pnas.0711401105 18192399 (Pubitemid 351282069)
51. alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Allen SJ, O'Donnell A, Alexander ND, Alpers MP, Peto TE, Clegg JB, Weatherall DJ, Proc Natl Acad Sci USA 1997 94 14736 14741 10.1073/pnas.94.26.14736 9405682 (Pubitemid 28041443)
52. Hemoglobin variants and disease manifestations in severe falciparum malaria. May J, Evans JA, Timmann C, Ehmen C, Busch W, Thye T, Agbenyega T, Horstmann RD, JAMA 2007 297 2220 2226 10.1001/jama.297.20.2220 17519411 (Pubitemid 47010879)
53. Increased microerythrocyte count in homozygous alpha(+)-thalassaemia contributes to protection against severe malarial anaemia. Fowkes FJ, Allen SJ, Allen A, Alpers MP, Weatherall DJ, Day KP, PLoS Med 2008 5 56 10.1371/journal.pmed.0050056 18351796 (Pubitemid 351471698)
54. Protection by alpha-thalassaemia against Plasmodium falciparum malaria: modified surface antigen expression rather than impaired growth or cytoadherence. Luzzi GA, Merry AH, Newbold CI, Marsh K, Pasvol G, Immunol Lett 1991 30 233 240 10.1016/0165-2478(91)90031-5 1757109
55. The interaction of malaria parasites with red blood cells. Pasvol G, Wilson RJ, Br Med Bull 1982 38 133 140 7052193 (Pubitemid 12008182)
56. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, Drousiotou A, Dangerfield B, Lefranc G, Loiselet J, Piro A, Stoneking M, Tagarelli A, Tagarelli G, Touma EH, Williams SM, Clark AG, Science 2001 293 455 462 10.1126/science.1061573 11423617 (Pubitemid 32679066)
57. Malaria in African children with deficient erythrocyte glucose-6-phosphate dehydrogenase. Allison AC, Clyde DF, Br Med J 1961 1 1346 1349 10.1136/bmj.1.5236.1346 13682585
58. Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant. Bienzle U, Ayeni O, Lucas AO, Luzzatto L, Lancet 1972 1 107 110 4108978
59. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, Newbold CI, Greenwood BM, Marsh K, Hill AVS, Nature 1995 376 246 249 10.1038/376246a0 7617034
60. Pyruvate kinase deficiency protects against malaria in humans. Durand PM, Coetzer TL, Haematologica 2008 93 939 940 10.3324/haematol.12450 18460648 (Pubitemid 351821735)
61. Ability of Plasmodium falciparum to invade Southeast Asian ovalocytes varies between parasite lines. Cortes A, Benet A, Cooke BM, Barnwell JW, Reeder JC, Blood 2004 104 2961 2966 10.1182/blood-2004-06-2136 15265796 (Pubitemid 39434988)
62. Adhesion of Plasmodium falciparum-infected red blood cells to CD36 under flow is enhanced by the cerebral malaria-protective trait South-East Asian ovalocytosis. Cortes A, Mellombo M, Mgone CS, Beck HP, Reeder JC, Cooke BM, Mol Biochem Parasitol 2005 142 252 257 10.1016/j.molbiopara.2005.03.016 15978955 (Pubitemid 40835917)
63. Erythrocytes carrying mutations in spectrin and protein 4.1 show differing sensitivities to invasion by Plasmodium falciparum. Facer CA, Parasitol Res 1995 81 52 57 10.1007/BF00932417 7724514 (Pubitemid 24363560)
64. Rapidly evolving genes in human. I. The glycophorins and their possible role in evading malaria parasites. Wang HY, Tang H, Shen CK, Wu CI, Mol Biol Evol 2003 20 1795 1804 10.1093/molbev/msg185 12949139 (Pubitemid 37420932)
65. Reflections on effective leadership: strains and successes, strategies and styles. Blumenfield S, Soc Work Health Care 1995 20 21 37 10.1300/J010v20n04-03 8578430
66. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Kone A, Diallo DA, Raza A, Kai O, Marsh K, Plowe CV, Doumbo OK, Moulds JM, Proc Natl Acad Sci USA 2007 104 17471 17476 10.1073/pnas.0705390104 17959777 (Pubitemid 350219862)
67. Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting. Barragan A, Kremsner PG, Wahlgren M, Carlson J, Infect Immun 2000 68 2971 2975 10.1128/IAI.68.5.2971-2975.2000 10768996 (Pubitemid 30253879)
68. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, Miletich JP, Ridker PM, PLoS Genet 2008 4 1000118 10.1371/journal.pgen.1000118 18604267
69. Association of the haptoglobin phenotype (1-1) with falciparum malaria in Sudan. Elagib AA, Kider AO, Akerstrom B, Elbashir MI, Trans R Soc Trop Med Hyg 1998 92 309 311 10.1016/S0035-9203(98)91025-2 9861405 (Pubitemid 28286932)
70. Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria. Quaye IK, Ekuban FA, Goka BQ, Adabayeri V, Kurtzhals JA, Gyan B, Ankrah NA, Hviid L, Akanmori BD, Trans R Soc Trop Med Hyg 2000 94 216 219 10.1016/S0035-9203(00)90281-5 10897372 (Pubitemid 30307300)
71. Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A-61C) may explain previous controversy of haptoglobin and malaria protection. Cox SE, Doherty C, Atkinson SH, Nweneka CV, Fulford AJ, Ghattas H, Rockett KA, Kwiatkowski DP, Prentice AM, PLoS One 2007 2 362 10.1371/journal.pone.0000362 17426810
72. Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG, J Infect Dis 2001 184 330 336 10.1086/322037 11443559 (Pubitemid 32662180)
73. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, Mwaikambo ED, Lal AL, Granger DL, Anstey NM, Weinberg JB, Lancet 2002 360 1468 1475 10.1016/S0140-6736(02)11474-7 12433515 (Pubitemid 35356325)
74. Common west African HLA antigens are associated with protection from severe malaria. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM, Nature 1991 352 595 600 10.1038/352595a0 1865923 (Pubitemid 21912384)
75. Association of malaria parasite population structure, HLA, and immunological antagonism. Gilbert SC, Plebanski M, Gupta S, Morris J, Cox M, Aidoo M, Kwiatkowski D, Greenwood BM, Whittle HC, Hill AV, Science 1998 279 1173 1177 10.1126/science.279.5354.1173 9469800 (Pubitemid 28164361)
76. Inverse associations of human leukocyte antigen and malaria parasite types in two West African populations. Young K, Frodsham A, Doumbo OK, Gupta S, Dolo A, Hu JT, Robson KJ, Crisanti A, Hill AV, Gilbert SC, Infect Immun 2005 73 953 955 10.1128/IAI.73.2.953-955.2005 15664937 (Pubitemid 40165754)
77. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D, J Infect Dis 1999 179 287 290 10.1086/314533 9841857 (Pubitemid 29028373)
78. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D, Nature 1994 371 508 510 10.1038/371508a0 7935762
79. Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Atkinson SH, Rockett KA, Morgan G, Bejon PA, Sirugo G, O'Connell MA, Hanchard N, Kwiatkowski DP, Prentice AM, Blood 2008 112 4276 4283 10.1182/blood-2008-06-162008 18716131
80. Evidence that interferon-gamma plays a protective role during cerebral malaria. Cabantous S, Poudiougou B, Traore A, Keita M, Cisse MB, Doumbo O, Dessein AJ, Marquet S, J Infect Dis 2005 192 854 860 10.1086/432484 16088835 (Pubitemid 41193083)
81. IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. Koch O, Awomoyi A, Usen S, Jallow M, Richardson A, Hull J, Pinder M, Newport M, Kwiatkowski D, J Infect Dis 2002 185 1684 1687 10.1086/340516 12023780 (Pubitemid 34587536)
82. Interferon regulatory factor-1 polymorphisms are associated with the control of Plasmodium falciparum infection. Mangano VD, Luoni G, Rockett KA, Sirima BS, Konate A, Forton J, Clark TG, Bancone G, Sadighi Akha E, Kwiatkowski DP, Modiano D, Genes Immun 2008 9 122 129 10.1038/sj.gene.6364456 18200030 (Pubitemid 351351655)
83. Lack of association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populations. Mangano VD, Clark TG, Auburn S, Campino S, Diakite M, Fry AE, Green A, Richardson A, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Newton C, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Modiano D, Kwiatkowski DP, Rockett KA, PLoS One 2009 4 4206 10.1371/journal.pone.0004206 19145247
84. CD40L association with protection from severe malaria. Sabeti P, Usen S, Farhadian S, Jallow M, Doherty T, Newport M, Pinder M, Ward R, Kwiatkowski D, Genes Immun 2002 3 286 291 10.1038/sj.gene.6363877 12140747 (Pubitemid 38967554)
85. Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Walley AJ, Aucan C, Kwiatkowski D, Hill AV, Eur J Hum Genet 2004 12 132 138 10.1038/sj.ejhg.5201084 14673470 (Pubitemid 38263558)
86. Polymorphisms in interleukin-1beta and interleukin-1 receptor antagonist genes and malaria in Ghanaian children. Gyan B, Goka B, Cvetkovic JT, Perlmann H, Lefvert AK, Akanmori B, Troye-Blomberg M, Scand J Immunol 2002 56 619 622 10.1046/j.1365-3083.2002.01161.x 12472674 (Pubitemid 35454345)
87. A functional polymorphism in the IL1B gene promoter, IL1B -31C > T, is not associated with cerebral malaria in Thailand. Ohashi J, Naka I, Doi A, Patarapotikul J, Hananantachai H, Tangpukdee N, Looareesuwan S, Tokunaga K, Malar J 2005 4 38 10.1186/1475-2875-4-38 16098232 (Pubitemid 41367698)
88. Antimalarial antibody levels and IL4 polymorphism in the Fulani of West Africa. Luoni G, Verra F, Arca B, Sirima BS, Troye-Blomberg M, Coluzzi M, Kwiatkowski D, Modiano D, Genes Immun 2001 2 411 414 10.1038/sj.gene.6363797 11704810 (Pubitemid 33674259)
89. IL4-589C/T polymorphism and IgE levels in severe malaria. Verra F, Luoni G, Calissano C, Troye-Blomberg M, Perlmann P, Perlmann H, Arca B, Sirima BS, Konate A, Coluzzi M, Kwiatkowski D, Modiano D, Acta Trop 2004 90 205 209 10.1016/j.actatropica.2003.11.014 15177147 (Pubitemid 38283770)
90. Associations between the IL-4 -590 T allele and Plasmodium falciparum infection prevalence in asymptomatic Fulani of Mali. Vafa M, Maiga B, Berzins K, Hayano M, Bereczky S, Dolo A, Daou M, Arama C, Kouriba B, Farnert A, Doumbo OK, Troye-Blomberg M, Microbes Infect 2007 9 1043 1048 10.1016/j.micinf.2007.04.011 17662633 (Pubitemid 47299212)
91. Relative levels of IL4 and IFN-gamma in complicated malaria: association with IL4 polymorphism and peripheral parasitemia. Tangteerawatana P, Pichyangkul S, Hayano M, Kalambaheti T, Looareesuwan S, Troye-Blomberg M, Khusmith S, Acta Trop 2007 101 258 265 10.1016/j.actatropica.2007.02.008 17379175 (Pubitemid 46522528)
92. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Gyan BA, Goka B, Cvetkovic JT, Kurtzhals JL, Adabayeri V, Perlmann H, Lefvert AK, Akanmori BD, Troye-Blomberg M, Clin Exp Immunol 2004 138 145 150 10.1111/j.1365-2249.2004. 02590.x 15373917 (Pubitemid 39279977)
93. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB, Vulule JM, Martinson J, Ong'echa JM, Ferrell RE, Perkins DJ, Hum Genet 2008 124 515 524 10.1007/s00439-008-0578-5 18972133
94. Investigation of malaria susceptibility determinants in the IFNG/IL26/IL22 genomic region. Koch O, Rockett K, Jallow M, Pinder M, Sisay-Joof F, Kwiatkowski D, Genes Immun 2005 6 312 318 10.1038/sj.gene.6364214 15858598 (Pubitemid 40903404)
95. FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan. Nasr A, Iriemenam NC, Giha HA, Balogun HA, Anders RF, Troye-Blomberg M, ElGhazali G, Berzins K, Malar J 2009 8 43 10.1186/1475-2875-8-43 19284648
96. Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. Shi YP, Nahlen BL, Kariuki S, Urdahl KB, McElroy PD, Roberts JM, Lal AA, J Infect Dis 2001 184 107 111 10.1086/320999 11398118 (Pubitemid 32568509)
97. Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients. Nasr A, Iriemenam NC, Troye-Blomberg M, Giha HA, Balogun HA, Osman OF, Montgomery SM, ElGhazali G, Berzins K, Scand J Immunol 2007 66 87 96 10.1111/j.1365-3083.2007.01947.x 17587350 (Pubitemid 46991978)
98. Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. Cooke GS, Aucan C, Walley AJ, Segal S, Greenwood BM, Kwiatkowski DP, Hill AV, Am J Trop Med Hyg 2003 69 565 568 14740869 (Pubitemid 38248224)
99. Absence of association between the Fc gamma receptor IIIA-176F/V polymorphism and the severity of malaria in Thai. Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, Looareesuwan S, Tokunaga K, Jpn J Infect Dis 2002 55 167 169 12501257 (Pubitemid 36150477)
100. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N, Watkins NA, Floto RA, Smith KG, Proc Natl Acad Sci USA 2007 104 7169 7174 10.1073/pnas.0608889104 17435165 (Pubitemid 47186027)
101. Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. Mockenhaupt FP, Hamann L, von Gaertner C, Bedu-Addo G, von Kleinsorgen C, Schumann RR, Bienzle U, J Infect Dis 2006 194 184 188 10.1086/505152 16779724 (Pubitemid 44087189)
102. Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. Leoratti FM, Farias L, Alves FP, Suarez-Mutis MC, Coura JR, Kalil J, Camargo EP, Moraes SL, Ramasawmy R, J Infect Dis 2008 198 772 780 10.1086/590440 18662133
103. Low frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy. Hamann L, Kumpf O, Schuring RP, Alpsoy E, Bedu-Addo G, Bienzle U, Oskam L, Mockenhaupt FP, Schumann RR, BMC Med Genet 2009 10 65 19602285
104. DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria. Uhlemann AC, Szlezak NA, Vonthein R, Tomiuk J, Emmer SA, Lell B, Kremsner PG, Kun JF, J Infect Dis 2004 189 2227 2234 10.1086/421242 15181570 (Pubitemid 38757195)
105. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. Luty AJ, Kun JF, Kremsner PG, J Infect Dis 1998 178 1221 1224 10.1086/515690 9806066 (Pubitemid 28452230)
106. Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Garred P, Nielsen MA, Kurtzhals JA, Malhotra R, Madsen HO, Goka BQ, Akanmori BD, Sim RB, Hviid L, Infect Immun 2003 71 5245 5253 10.1128/IAI.71.9.5245-5253.2003 12933871 (Pubitemid 37070771)
107. Mannose-binding lectin variant associated with severe malaria in young African children. Holmberg V, Schuster F, Dietz E, Sagarriga Visconti JC, Anemana SD, Bienzle U, Mockenhaupt FP, Microbes Infect 2008 10 342 348 10.1016/j.micinf.2007.12.008 18396436
108. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Rowe JA, Moulds JM, Newbold CI, Miller LH, Nature 1997 388 292 295 10.1038/40888 9230440 (Pubitemid 27317975)
109. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Cockburn IA, Mackinnon MJ, O'Donnell A, Allen SJ, Moulds JM, Baisor M, Bockarie M, Reeder JC, Rowe JA, Proc Natl Acad Sci USA 2004 101 272 277 10.1073/pnas.0305306101 14694201 (Pubitemid 38084240)
110. Variations in host genes encoding adhesion molecules and susceptibility to falciparum malaria in India. Sinha S, Qidwai T, Kanchan K, Anand P, Jha GN, Pati SS, Mohanty S, Mishra SK, Tyagi PK, Sharma SK, Venkatesh V, Habib S, Malar J 2008 7 250 10.1186/1475-2875-7-250 19055786
111. Plasmodium falciparum malaria in south-west Nigerian children: is the polymorphism of ICAM-1 and E-selectin genes contributing to the clinical severity of malaria? Amodu OK, Gbadegesin RA, Ralph SA, Adeyemo AA, Brenchley PE, Ayoola OO, Orimadegun AE, Akinsola AK, Olumese PE, Omotade OO, Acta Trop 2005 95 248 255 10.1016/j.actatropica.2005.05.011 16002039 (Pubitemid 41207288)
112. Variation in the ICAM1 gene is not associated with severe malaria phenotypes. Fry AE, Auburn S, Diakite M, Green A, Richardson A, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Rockett KA, Kwiatkowski DP, Genes Immun 2008 9 462 469 10.1038/gene.2008.38 18528404
113. Genetic study of ICAM1 in clinical malaria in Senegal. Ndiaye R, Sakuntabhai A, Casademont I, Rogier C, Tall A, Trape JF, Spiegel A, Dieye A, Julier C, Tissue Antigens 2005 65 474 480 10.1111/j.1399-0039.2005.00388.x 15853902 (Pubitemid 40592941)
114. Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains. Kun JF, Lehman LG, Lell B, Schmidt-Ott R, Kremsner PG, Antimicrob Agents Chemother 1999 43 2205 2208 10471565 (Pubitemid 29421201)
115. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Fernandez-Reyes D, Craig AG, Kyes SA, Peshu N, Snow RW, Berendt AR, Marsh K, Newbold CI, Hum Mol Genet 1997 6 1357 1360 10.1093/hmg/6.8.1357 9259284 (Pubitemid 27351078)
116. Association of adhesion molecule PECAM-1/CD31 polymorphism with susceptibility to cerebral malaria in Thais. Kikuchi M, Looareesuwan S, Ubalee R, Tasanor O, Suzuki F, Wattanagoon Y, Na-Bangchang K, Kimura A, Aikawa M, Hirayama K, Parasitol Int 2001 50 235 239 10.1016/S1383-5769(01)00082-4 11719109 (Pubitemid 33062369)
117. Short report: codon 125 polymorphism of CD31 and susceptibility to malaria. Casals-Pascual C, Allen S, Allen A, Kai O, Lowe B, Pain A, Roberts DJ, Am J Trop Med Hyg 2001 65 736 737 11791967 (Pubitemid 34049465)
118. CD36 polymorphism is associated with protection from cerebral malaria. Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, Looareesuwan S, Tokunaga K, Am J Hum Genet 2003 72 364 374 10.1086/346091 12506336 (Pubitemid 36194245)
119. Malaria susceptibility and CD36 mutation. Aitman TJ, Cooper LD, Norsworthy PJ, Wahid FN, Gray JK, Curtis BR, McKeigue PM, Kwiatkowski D, Greenwood BM, Snow RW, Hill AV, Scott J, Nature 2000 405 1015 1016 10.1038/35016636 10890433 (Pubitemid 30447776)
120. A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Pain A, Urban BC, Kai O, Casals-Pascual C, Shafi J, Marsh K, Roberts DJ, Lancet 2001 357 1502 1503 10.1016/S0140-6736(00)04662-6 11377606 (Pubitemid 32488864)
121. A variant in the gene FUT9 is associated with susceptibility to placental malaria infection. Sikora M, Ferrer-Admetlla A, Laayouni H, Menendez C, Mayor A, Bardaji A, Sigauque B, Mandomando I, Alonso PL, Bertranpetit J, Casals F, Hum Mol Genet 2009 18 3136 3144 10.1093/hmg/ddp240 19460885
122. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM, Lancet 1990 336 1201 1204 10.1016/0140-6736(90)92827-5 1978068 (Pubitemid 20382913)
123. Tumor necrosis factor and disease severity in children with falciparum malaria. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH, N Engl J Med 1989 320 1586 1591 10.1056/NEJM198906153202404 2657427 (Pubitemid 19154572)
124. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Charoenvit Y, Majam VF, Corradin G, Sacci JB Jr, Wang R, Doolan DL, Jones TR, Abot E, Patarroyo ME, Guzman F, Hoffman SL, Infect Immun 1999 67 5604 5614 10531206 (Pubitemid 29508076)
125. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Migot-Nabias F, Deloron P, Nussenzweig RS, Kremsner PG, J Infect Dis 1999 179 980 988 10.1086/314689 10068595 (Pubitemid 29159345)
126. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Bach EA, Aguet M, Schreiber RD, Annu Rev Immunol 1997 15 563 591 10.1146/annurev. immunol.15.1.563 9143700 (Pubitemid 27169292)
127. Roles of interferon-regulatory factors in T-helper-cell differentiation. Lohoff M, Mak TW, Nat Rev Immunol 2005 5 125 135 10.1038/nri1552 15688040 (Pubitemid 40208902)
128. Detecting recent positive selection in the human genome from haplotype structure. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner SF, Gabriel SB, Platko JV, Patterson NJ, McDonald GJ, Ackerman HC, Campbell SJ, Altshuler D, Cooper R, Kwiatkowski D, Ward R, Lander ES, Nature 2002 419 832 837 10.1038/nature01140 12397357 (Pubitemid 35238568)
129. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Dunn E, Sims JE, Nicklin MJ, O'Neill LA, Trends Immunol 2001 22 533 536 10.1016/S1471-4906(01)02034-8 11574261 (Pubitemid 33016389)
130. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH, Science 1994 264 1152 1156 10.1126/science.8178175 8178175 (Pubitemid 24210678)
131. Interleukin-10 and related cytokines and receptors. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB, Annu Rev Immunol 2004 22 929 979 10.1146/annurev.immunol.22.012703.104622 15032600 (Pubitemid 38680445)
132. IL-22 increases the innate immunity of tissues. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R, Immunity 2004 21 241 254 10.1016/j.immuni. 2004.07.007 15308104 (Pubitemid 39094053)
133. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Bolland S, Ravetch JV, Immunity 2000 13 277 285 10.1016/S1074-7613(00)00027-3 10981970
134. Functions of toll-like receptors: lessons from KO mice. Akira S, Takeda K, C R Biol 2004 327 581 589 10.1016/j.crvi.2004.04.002 15330257 (Pubitemid 38979508)
135. Toll-like receptors - sentries in the B-cell response. Bekeredjian-Ding I, Jego G, Immunology 2009 128 311 323 10.1111/j.1365-2567.2009.03173.x 20067531
136. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, Yamamoto M, Takeuchi O, Itagaki S, Kumar N, Horii T, Akira S, J Exp Med 2005 201 19 25 10.1084/jem.20041836 15630134 (Pubitemid 40130079)
137. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Treutiger CJ, Heddini A, Fernandez V, Muller WA, Wahlgren M, Nat Med 1997 3 1405 1408 10.1038/nm1297-1405 9396614 (Pubitemid 28011044)